Health Trials

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

ConditionsAdvanced Thyroid Gland Medullary CarcinomaStage III Thyroid Gland Medullary Carcinoma AJCC v8Stage IV Thyroid Gland Medullary Carcinoma AJCC v8Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.

Eligibility criteria

Qualifiers

Aims 1 and 2: A diagnosis of MTC

Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment

Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team

Aim 3: A current registrant in the MTCR

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Blood Pressure Measurement
  • Questionnaire Administration

Treatment groups

2,030 Participants
are divided into 1 treatment group

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov